An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...
